Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Boursi

Showing results (31-40 of 106) with videos related to

Pageof 11
Sort By:
Digestive Diseases and Sciences|February 20, 2016
A Risk Prediction Model for Sporadic CRC Based on Routine Lab ResultsBen Boursi, Ronac Mamtani, Wei-Ting Hwang, et al.
American Journal of Hematology|March 9, 2016
Reappraisal of risk factors for monoclonal gammopathy of undetermined significanceBen Boursi, Brendan M Weiss, Kevin Haynes, et al.
The Journal of Urology|January 27, 2016
Association of Itraconazole, a Hedgehog Inhibitor, and Bladder CancerRonac Mamtani, Yu-Xiao Yang, Frank I Scott, et al.
The Israel Medical Association Journal : IMAJ|October 28, 2025
Evaluating Outcomes of FLOT protocol in Elderly Patients with Locally Advanced Gastric AdenocarcinomaBen Ramon, Amos Stemmer, Keren Levanon, et al.
Cancer Epidemiology|December 28, 2025
The effect of metformin exposure on colorectal cancer incidence according to tumor sidednessYehudit Peerless, Gal Strauss, Ofer Margalit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2021
Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment ResistanceLir Beck, Michal Harel, Shun Yu, et al.
Targeted Oncology|May 10, 2021
Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance StudyAdam Goldman, David Bomze, Rachel Dankner, et al.
British Journal of Clinical Pharmacology|September 23, 2020
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reportsAdam Goldman, David Bomze, Rachel Dankner, et al.
Pancreas|April 11, 2022
Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World DataBen Boursi, Tal Patalon, Muriel Webb, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2016
Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcomeBen Boursi, Bruce J Giantonio, James D Lewis, et al.
Pageof 11

Showing results (31-40 of 106) with videos related to

Sort By:
Pageof 11
Digestive Diseases and Sciences|February 20, 2016
A Risk Prediction Model for Sporadic CRC Based on Routine Lab ResultsBen Boursi, Ronac Mamtani, Wei-Ting Hwang, et al.
American Journal of Hematology|March 9, 2016
Reappraisal of risk factors for monoclonal gammopathy of undetermined significanceBen Boursi, Brendan M Weiss, Kevin Haynes, et al.
The Journal of Urology|January 27, 2016
Association of Itraconazole, a Hedgehog Inhibitor, and Bladder CancerRonac Mamtani, Yu-Xiao Yang, Frank I Scott, et al.
The Israel Medical Association Journal : IMAJ|October 28, 2025
Evaluating Outcomes of FLOT protocol in Elderly Patients with Locally Advanced Gastric AdenocarcinomaBen Ramon, Amos Stemmer, Keren Levanon, et al.
Cancer Epidemiology|December 28, 2025
The effect of metformin exposure on colorectal cancer incidence according to tumor sidednessYehudit Peerless, Gal Strauss, Ofer Margalit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 15, 2021
Clinical Proteomics of Metastatic Melanoma Reveals Profiles of Organ Specificity and Treatment ResistanceLir Beck, Michal Harel, Shun Yu, et al.
Targeted Oncology|May 10, 2021
Cardiovascular Toxicities of Antiangiogenic Tyrosine Kinase Inhibitors: A Retrospective, Pharmacovigilance StudyAdam Goldman, David Bomze, Rachel Dankner, et al.
British Journal of Clinical Pharmacology|September 23, 2020
Cardiovascular adverse events associated with hydroxychloroquine and chloroquine: A comprehensive pharmacovigilance analysis of pre-COVID-19 reportsAdam Goldman, David Bomze, Rachel Dankner, et al.
Pancreas|April 11, 2022
Validation of the Enriching New-Onset Diabetes for Pancreatic Cancer Model: A Retrospective Cohort Study Using Real-World DataBen Boursi, Tal Patalon, Muriel Webb, et al.
European Journal of Cancer (Oxford, England : 1990)|March 28, 2016
Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcomeBen Boursi, Bruce J Giantonio, James D Lewis, et al.
Pageof 11